Materials and methods
We identified 63 polyps (37 adenomas and 26 hyperplastic polyps) from 34 subjects with known germline MMR gene mutations. Clinicopathological information for each polyp was obtained from retrospective review of pathology reports. MSI analysis was performed on microdissected polyp DNA using pentaplex PCR for a panel of five quasimonomorphic mononucleotide repeat sequences [1] . If ≥2/5 sequences were mutated, the polyp was determined to have MSI.
Results
MSI was identified in 14/37 (38%) adenomas, compared with 3/26 (12%) hyperplastic polyps (p = 0.021). Prevalence of MSI was significantly higher in larger polyps; among the lesions ≥10mm, 6/7 (86%) adenomas and 1/1 (100%) hyperplastic polyps demonstrated MSI. There was no association between MSI status and patient sex, polyp location, or the patient's underlying MMR gene mutation. Although MSI appeared more prevalent in adenomas from individuals ≥age 50 years (53% vs 22% for age<50), this did not achieve statistical significance (p = 0.057).
Conclusions
Overall, MSI was detected in 38% of adenomas and 12% of hyperplastic polyps from individuals with MMR mutations. MSI analysis of small colorectal adenomas would have low sensitivity for identifying patients who should be considered for genetic testing for Lynch syndrome. The finding of MSI in a small fraction of hyperplastic polyps raises questions about their neoplastic potential in patients with Lynch syndrome. 
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